((lp0
VisWord
p1
aVcase
p2
aVstops
p3
aVstem
p4
accopy_reg
_reconstructor
p5
(cnltk.probability
FreqDist
p6
c__builtin__
dict
p7
(dp8
S'heart study logistic regression coeffici'
p9
I1
sS'of peripheral alpha-1'
p10
I1
sS'doxazosin arm termin'
p11
I1
sS'arm of allhat'
p12
I1
sS'trial compar'
p13
I1
sS'plasma norepinephrin'
p14
I1
sS'terazosin'
p15
I3
sS'active-control tri'
p16
I1
sS'cardiac receptor'
p17
I1
sS'outcome of chd'
p18
I1
sS'second-line anti-hypertensive therapi'
p19
I1
sS'diverse patient popul'
p20
I1
sS'find'
p21
I2
sS'antihypertensive therapi'
p22
I1
sS'clinical present'
p23
I1
sS'plasma volume fluid expans'
p24
I1
sS'doxazosin arm'
p25
I3
sS'doxazosin arm of'
p26
I1
sS'myocardial damag'
p27
I1
sS'systolic blood'
p28
I3
sS'myocyt'
p29
I2
sS'harmful effect of'
p30
I1
sS'cellular injuri'
p31
I1
sS'assay'
p32
I1
sS'medical care survey'
p33
I1
sS'normotensive pati'
p34
I1
sS'express'
p35
I1
sS'peripheral alpha-1 antagonists for low'
p36
I1
sS'fluid'
p37
I1
sS'fractional excret'
p38
I1
sS'treatment of'
p39
I1
sS'low-dose chlorthalidon'
p40
I2
sS'cellular'
p41
I1
sS'of total mort'
p42
I1
sS'alpha-1'
p43
I1
sS'norepinephrin'
p44
I4
sS'for th'
p45
I1
sS'peripheral alpha-1'
p46
I14
sS'acute renal effect of prazosin'
p47
I1
sS'primary outcome of'
p48
I1
sS'prazosin blocks heat shock protein'
p49
I1
sS'cardiovascular diseas'
p50
I1
sS'total mort'
p51
I1
sS'fluid status peripheral alpha-1 antagonist'
p52
I1
sS'trial arm'
p53
I1
sS'symptomatic episod'
p54
I1
sS'allhat'
p55
I13
sS'hypertension therapi'
p56
I1
sS'comparative tri'
p57
I1
sS'framingham'
p58
I1
sS'wyeth'
p59
I1
sS'arm'
p60
I5
sS'prazosin arm'
p61
I1
sS'subject'
p62
I1
sS'cellular effects physiolog'
p63
I1
sS'excretion of sodium'
p64
I1
sS'treatment of mild hypertension studi'
p65
I1
sS'homeostasi'
p66
I1
sS'particip'
p67
I3
sS'endothelin-1'
p68
I1
sS'physiolog'
p69
I1
sS'ecfv'
p70
I1
sS'clinical epidemiology fellow'
p71
I1
sS'chronic sodium'
p72
I1
sS'cardiac damag'
p73
I1
sS'men'
p74
I1
sS'physiologic literatur'
p75
I2
sS'for prazosin'
p76
I1
sS'coeffici'
p77
I1
sS'congestive heart'
p78
I1
sS'treatment of mild hypertens'
p79
I1
sS'toler'
p80
I2
sS'epidemiology fellow'
p81
I1
sS'interpret'
p82
I1
sS'popul'
p83
I4
sS'search'
p84
I1
sS'fluid statu'
p85
I1
sS'chronic congestive heart'
p86
I1
sS'retent'
p87
I1
sS'fluid expans'
p88
I2
sS'trial'
p89
I15
sS'survey'
p90
I1
sS'committe'
p91
I1
sS'allhat particip'
p92
I1
sS'lipid-lowering treat'
p93
I1
sS'studi'
p94
I5
sS'subclinical ventricular dysfunct'
p95
I1
sS'heart failure occurr'
p96
I1
sS'episod'
p97
I1
sS'heart'
p98
I7
sS'clonidin'
p99
I2
sS'study logistic regression coeffici'
p100
I1
sS'of prazosin'
p101
I2
sS'framingham heart study logistic regression coeffici'
p102
I1
sS'framingham heart study logist'
p103
I1
sS'blockad'
p104
I1
sS'jnc vi'
p105
I1
sS'study popul'
p106
I1
sS'peripheral alpha-1 antagonists for'
p107
I1
sS'damag'
p108
I2
sS'of heart'
p109
I1
sS'chd'
p110
I1
sS'lund-johansen'
p111
I1
sS'chf'
p112
I8
sS'injuri'
p113
I2
sS'peripheral alpha-1 antagonists for lowering blood'
p114
I1
sS'lipid-low'
p115
I1
sS'fractional excretion of'
p116
I1
sS'recommend'
p117
I1
sS'sodium homeostasi'
p118
I1
sS'heart attack'
p119
I1
sS'routine use of'
p120
I1
sS'acute renal effect of'
p121
I1
sS'diastolic blood'
p122
I1
sS'fractional excretion of sodium'
p123
I1
sS'subclinical diseas'
p124
I1
sS'hypertension studi'
p125
I1
sS'efficaci'
p126
I1
sS'shep trial'
p127
I3
sS'erst'
p128
I1
sS'cardiovascular outcom'
p129
I1
sS'inhibit'
p130
I1
sS'endpoint'
p131
I4
sS'physiology studi'
p132
I1
sS'cellular repair'
p133
I1
sS'ramif'
p134
I1
sS'randomized tri'
p135
I1
sS'english-language pap'
p136
I1
sS'outcom'
p137
I2
sS'national ambulatory medical care survey'
p138
I1
sS'arm termin'
p139
I1
sS'hypertrophi'
p140
I1
sS'va'
p141
I1
sS'complic'
p142
I1
sS'tolerability tri'
p143
I1
sS'histologic evid'
p144
I1
sS'vi'
p145
I1
sS'von'
p146
I1
sS'clinical heart failure ev'
p147
I1
sS'physiologic studi'
p148
I2
sS'trial comparing atenolol'
p149
I1
sS'peripheral alpha-1 antagonist'
p150
I17
sS'epidemiologic research'
p151
I1
sS'shep particip'
p152
I1
sS'chronic therapi'
p153
I2
sS'captopril'
p154
I2
sS'risk'
p155
I2
sS'low-dose diuret'
p156
I3
sS'cohort'
p157
I1
sS'differenti'
p158
I1
sS'fluid status peripheral alpha-1'
p159
I1
sS'pharmacologic treat'
p160
I1
sS'benign prostatic hypertrophi'
p161
I1
sS'concentration of'
p162
I1
sS'allhat popul'
p163
I1
sS'hypertens'
p164
I1
sS'clinical presentation of'
p165
I1
sS'higher'
p166
I1
sS'of norepinephrin'
p167
I1
sS'evid'
p168
I2
sS'ser clinical epidemiology fellow'
p169
I1
sS'expans'
p170
I6
sS'of allhat'
p171
I1
sS'prostatism evid'
p172
I1
sS'cellular effects physiologic studi'
p173
I1
sS'blood'
p174
I2
sS'associ'
p175
I1
sS'heart failure find'
p176
I1
sS'the pharmacologic treat'
p177
I1
sS'secondary outcom'
p178
I2
sS'original baselin'
p179
I1
sS'rat myocyt'
p180
I1
sS'framingham heart study logistic regress'
p181
I1
sS'national ambulatori'
p182
I1
sS'attack tri'
p183
I1
sS'withdraw'
p184
I2
sS'secondary outcome of total mort'
p185
I1
sS'load'
p186
I2
sS'life-prolonging therapi'
p187
I1
sS'comparing atenolol'
p188
I1
sS'prazosin decreas'
p189
I1
sS'blocker'
p190
I1
sS'dose'
p191
I1
sS'jnc'
p192
I1
sS'intensive dietary counsel'
p193
I1
sS'clinic'
p194
I1
sS'paper'
p195
I1
sS'fluid status peripher'
p196
I1
sS'clinical presentation of heart'
p197
I1
sS'demograph'
p198
I1
sS'routine use of peripheral alpha-1'
p199
I1
sS'concentr'
p200
I1
sS'sodium'
p201
I5
sS'prazosin blocks heat shock protein express'
p202
I1
sS'stimul'
p203
I1
sS'radioisotopic assay'
p204
I1
sS'dysfunct'
p205
I1
sS'potential associ'
p206
I1
sS'va cooperative studi'
p207
I1
sS'treatment'
p208
I4
sS'ventricular dysfunct'
p209
I1
sS'fluid retent'
p210
I1
sS'secondary outcome of'
p211
I1
sS'absolute risk reduction for clinical heart'
p212
I1
sS'plasma'
p213
I1
sS'concentration of norepinephrin'
p214
I1
sS'therapi'
p215
I6
sS'loss'
p216
I4
sS'myocardial injuri'
p217
I1
sS'nation'
p218
I2
sS'cardiovascular endpoint'
p219
I4
sS'antihypertens'
p220
I3
sS'peripher'
p221
I1
sS'framingham heart'
p222
I1
sS'mmhg'
p223
I1
sS'bph'
p224
I2
sS'hydrochlorothiazid'
p225
I2
sS'care survey'
p226
I1
sS'hypertensive pati'
p227
I2
sS'doxazosin gain'
p228
I1
sS'expansion for'
p229
I1
sS'routine use of peripheral alpha-1 antagonist'
p230
I1
sS'doxazosin arm of allhat'
p231
I1
sS'alpha-1 antagonist'
p232
I17
sS'absolute risk'
p233
I1
sS'dietary counsel'
p234
I1
sS'logistic regression coeffici'
p235
I1
sS'von willebrand'
p236
I1
sS'epidemiolog'
p237
I2
sS'laboratori'
p238
I1
sS'primary outcom'
p239
I1
sS'of doxazosin'
p240
I2
sS'medlin'
p241
I2
sS'patient popul'
p242
I1
sS'shep'
p243
I4
sS'mmhg higher'
p244
I1
sS'doxazosin'
p245
I13
sS'event'
p246
I5
sS'baselin'
p247
I2
sS'for'
p248
I1
sS'expansion for prazosin'
p249
I2
sS'renal effect of prazosin'
p250
I1
sS'research'
p251
I1
sS'profil'
p252
I1
sS'atenolol'
p253
I3
sS'myocardium'
p254
I1
sS'occurr'
p255
I2
sS'vascular hormon'
p256
I1
sS'diseas'
p257
I2
sS'patient'
p258
I3
sS'national committe'
p259
I1
sS'diltiazem'
p260
I1
sS'nonfatal heart failure ev'
p261
I1
sS'cholesterol'
p262
I2
sS'rahway'
p263
I1
sS'bibliographic search'
p264
I1
sS'ambulatory medical care survey'
p265
I1
sS'heart attack tri'
p266
I1
sS'chlorthalidon'
p267
I6
sS'relative risk'
p268
I1
sS'heart failure ev'
p269
I2
sS'doxazosin unmasking incipient heart'
p270
I1
sS'neurohormon'
p271
I1
sS'beta receptor stimul'
p272
I1
sS'diastolic hypertens'
p273
I1
sS'of'
p274
I2
sS'literatur'
p275
I1
sS'nonfatal heart'
p276
I1
sS'tomh'
p277
I1
sS'cardiovascular ev'
p278
I1
sS'clinical heart'
p279
I1
sS'mortal'
p280
I1
sS'prostat'
p281
I3
sS'national ambulatory medical car'
p282
I1
sS'total body sodium'
p283
I2
sS'perturb'
p284
I1
sS'beta block'
p285
I1
sS'clinical tri'
p286
I2
sS'receptor'
p287
I3
sS'lipid profil'
p288
I1
sS'diverse pati'
p289
I1
sS'diuret'
p290
I7
sS'prazosin'
p291
I5
sS'outcome of total mort'
p292
I1
sS'harmful effect of doxazosin'
p293
I1
sS'primary outcome of chd'
p294
I1
sS'termin'
p295
I3
sS'of sodium'
p296
I1
sS'shock protein express'
p297
I3
sS'kaplan-meier curv'
p298
I1
sS'status peripheral alpha-1 antagonist'
p299
I1
sS'gain'
p300
I6
sS'chlorthalidone arm'
p301
I2
sS'apoptosi'
p302
I1
sS'cooperative studi'
p303
I1
sS'symptom'
p304
I1
sS'chronic volume load'
p305
I1
sS'person-year'
p306
I2
sS'counsel'
p307
I1
sS'national ambulatory med'
p308
I1
sS'cardiotox'
p309
I1
sS'merck'
p310
I1
sS'cardiovascular compl'
p311
I1
sS'framingham heart studi'
p312
I1
sS'beta receptor'
p313
I2
sS'dose diuret'
p314
I1
sS'curv'
p315
I1
sS'for the pharmacologic treat'
p316
I3
sS'prostatic hypertrophi'
p317
I1
sS'absolute risk reduction for'
p318
I1
sS'protein express'
p319
I1
sS'plasma volume fluid'
p320
I1
sS'chronic sodium homeostasi'
p321
I1
sS'fellow'
p322
I1
sS'decreas'
p323
I1
sS'mild hypertension studi'
p324
I1
sS'of chd'
p325
I1
sS'nj'
p326
I1
sS'double-blind'
p327
I1
sS'antihypertensive efficaci'
p328
I1
sS'of peripheral alpha-1 antagonist'
p329
I5
sS'beta-block'
p330
I1
sS'receptor stimul'
p331
I1
sS'first-line blood'
p332
I1
sS'prazosin blocks heat shock'
p333
I1
sS'low-dose chlorthalidone arm'
p334
I1
sS'anti-hypertensive therapi'
p335
I1
sS'hormon'
p336
I1
sS'of mild hypertension studi'
p337
I1
sS'allhat tri'
p338
I2
sS'receptor inhibit'
p339
I1
sS'rr'
p340
I3
sS'antagonist'
p341
I20
sS'va coop'
p342
I1
sS'regression coeffici'
p343
I1
sS'treatment of mild'
p344
I1
stp345
Rp346
(dp347
S'_N'
p348
I592
sS'_max_cache'
p349
NsS'_item_cache'
p350
NsS'_Nr_cache'
p351
Nsbtp352
.